S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.74 (-1.51%)
NIO   3.87 (-3.25%)
BABA   68.78 (-0.15%)
T   16.38 (+0.31%)
F   12.16 (+0.83%)
MU   109.98 (-1.74%)
GE   152.66 (-0.18%)
CGC   8.20 (+4.73%)
DIS   111.97 (-0.41%)
AMC   3.12 (+6.85%)
PFE   25.40 (+0.04%)
PYPL   62.12 (+0.03%)
XOM   120.10 (+1.33%)
Free Trial
CVE:COT

Cotinga Pharmaceuticals Inc. (COT.V) (COT) Stock Price, News & Analysis

→ I’m officially sounding the alarm. (From Altimetry) (Ad)
Free COT Stock Alerts
C$0.04
-0.03 (-41.67%)
(As of 10/14/2020)
Compare
Today's Range
C$0.04
▼
C$0.04
50-Day Range
C$0.04
▼
C$0.04
52-Week Range
C$0.02
▼
C$0.12
Volume
1,000 shs
Average Volume
20,281 shs
Market Capitalization
C$769,510.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis

About Cotinga Pharmaceuticals Inc. (COT.V)

Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.

COT Stock Price History

COT Stock News Headlines

February 14, 2024 | wsj.com
Lexicon Pharmaceuticals Inc.
November 5, 2023 | morningstar.com
Acumen Pharmaceuticals Inc ABOS
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
July 22, 2023 | seekingalpha.com
SXTP 60 Degrees Pharmaceuticals, Inc.
April 28, 2023 | marketwatch.com
8-K: ENANTA PHARMACEUTICALS INC
February 18, 2023 | seekingalpha.com
Ironwood Pharmaceuticals, Inc. 2022 Q4 - Results - Earnings Call Presentation
January 24, 2023 | seekingalpha.com
PTPI Petros Pharmaceuticals, Inc.
October 11, 2022 | wsj.com
Amylyx Pharmaceuticals Inc.
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
August 12, 2022 | yahoo.com
PepGen Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
May 26, 2022 | finance.yahoo.com
Exagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conference
See More Headlines
Receive COT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cotinga Pharmaceuticals Inc. (COT.V) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:COT
CUSIP
N/A
CIK
N/A
Web
cotingapharma.com
Phone
+1-519-8585157
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.05
Quick Ratio
0.01

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.00 per share
Price / Cash Flow
17.50
Book Value
C($0.18) per share
Price / Book
-0.20

Miscellaneous

Outstanding Shares
21,986,000
Free Float
N/A
Market Cap
C$769,510.00
Optionable
Not Optionable
Beta
N/A
Beginners Guide To Retirement Stocks Cover
Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Ms. Alison D. Silva
    CEO, Pres & Director
  • Dr. Richard T. Ho (Age 58)
    Chief Scientific Officer
    Comp: $323.16k
  • Mr. Victor Hugo C.M.A. (Age 51)
    C.P.A., Chief Financial Officer
  • Mr. Paul Papi
    VP of Investor Relations

Key Competitors

View All Competitors

COT Stock Analysis - Frequently Asked Questions

How have COT shares performed in 2024?

Cotinga Pharmaceuticals Inc. (COT.V)'s stock was trading at C$0.04 at the beginning of 2024. Since then, COT stock has increased by 0.0% and is now trading at C$0.04.
View the best growth stocks for 2024 here.

Is Cotinga Pharmaceuticals Inc. (COT.V) a good dividend stock?

Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) pays an annual dividend of C$0.24 per share and currently has a dividend yield of 0.00%.

What other stocks do shareholders of Cotinga Pharmaceuticals Inc. (COT.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cotinga Pharmaceuticals Inc. (COT.V) investors own include Cascades (CAS), Aurora Cannabis (ACB), Advantage Lithium Corp. (AAL.V) (AAL), InPlay Oil (IPO), Harvest One Cannabis (HVT), Exchange Income (EIF), Datametrex AI (DM), Canadian National Railway (CNI) and Alimentation Couche-Tard (ATD.B).

How do I buy shares of Cotinga Pharmaceuticals Inc. (COT.V)?

Shares of COT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:COT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Biden’s $374B Giveaway Into This Sector
DTI
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative